Ascensia Diabetes Care and Senseonics Launch ‘The CGM for Real Life’ Campaign to Drive Awareness of Eversense E3 CGM System
Ascensia Diabetes Care and Senseonics Holdings have joined forces to launch a new advertising and marketing campaign called ‘The CGM for Real Life’ for the Eversense E3 CGM System. The campaign aims to raise awareness about Eversense E3 as a unique continuous glucose monitoring (CGM) option that is well-suited to support the everyday lives of people with diabetes.
According to a recent report, nearly 50% of people with diabetes who use short-term CGM systems are not fully satisfied with their current devices. Many individuals take breaks from using CGMs due to issues like sensors falling off prematurely or not wanting to have something attached to their bodies. Eversense E3 addresses these concerns by offering the longest sensor wear duration of six months and only requiring two sensor insertion and removal procedures per year.
‘The CGM for Real Life’ campaign aims to showcase the reality of living with diabetes and the challenges individuals face on a daily basis. It highlights how Eversense E3 provides a differentiated CGM option with unparalleled flexibility and long-term use, seamlessly integrating into real life.
Rudy Thoms, VP, CGM Commercial U.S. of Ascensia Diabetes Care, expressed excitement about challenging the status quo in continuous glucose monitoring. He believes that Eversense has the potential to be a game-changer for people with diabetes, and the campaign will help bring it to the attention of more individuals than ever before.
Chris Ruden, a Keynote Speaker and Eversense Brand Ambassador, shared his personal struggle with short-term CGMs and how Eversense has seamlessly fit into his life. Once inserted, he can forget about the hassle of replacements for six months, allowing him to live a busy life without diabetes getting in the way.
‘The CGM for Real Life’ campaign is a coordinated effort to raise awareness about Eversense E3 among people with diabetes and healthcare professionals. It includes advertising across connected TV, linear TV, digital platforms, and social media in five states. The goal is to inform individuals about the unique benefits of Eversense E3 and encourage them to consider it as a valuable CGM option.
For more information about Eversense E3, potential users can visit www.eversensecgm.com. Healthcare professionals interested in offering the Eversense E3 CGM System can sign up at www.bit.ly/eversense-become-provider or contact 1-844-SENSE4U (1-844-736-7348).
Ascensia Diabetes Care is a global company dedicated to helping people with diabetes. They offer innovative solutions, including the renowned CONTOUR portfolio of blood glucose monitoring systems. Ascensia collaborates closely with healthcare professionals and partners to ensure their products meet the highest standards of accuracy, precision, and reliability.
Senseonics Holdings is a medical technology company focused on developing and manufacturing glucose monitoring products. Their Eversense CGM systems utilize long-term implantable technology to provide continuous glucose monitoring for individuals with diabetes.
Overall, ‘The CGM for Real Life’ campaign aims to empower people with diabetes by providing them with a CGM option that seamlessly integrates into their everyday lives, offering flexibility and long-term use.